Workflow
Avadel Pharmaceuticals plc(AVDL)
icon
Search documents
Avadel Pharmaceuticals plc(AVDL) - 2021 Q3 - Earnings Call Transcript
2021-11-08 18:53
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2021 Earnings Conference Call November 8, 2021 8:30 AM ET Company Participants Courtney Turiano - Investor Relations Gregory Divis - Chief Executive Officer Tom McHugh - Chief Financial Officer Richard Kim - Chief Commercial Officer Jennifer Gudeman - Vice President of Medical and Clinical Affairs Conference Call Participants Christopher Howerton - Jefferies Francois Brisebois - Oppenheimer & Co. Inc. Ami Fadia - Needham & Co. Rudy Li - SVB Leerink David Amsellem ...
Avadel Pharmaceuticals plc(AVDL) - 2021 Q2 - Earnings Call Transcript
2021-08-09 16:39
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q2 2021 Earnings Conference Call August 9, 2021 8:30 AM ET Company Participants Courtney Turiano - Investor Relations Gregory Divis - Chief Executive Officer Tom McHugh - Chief Financial Officer Richard Kim - Chief Commercial Officer Jennifer Gudeman - Vice President of Medical and Clinical Affairs Conference Call Participants Paul Matteis - Stifel David Amsellem - Piper Sandler Francois Brisebois - Oppenheimer Oren Livnat - HC Wainwright Robin Garner - Craig -Hallum ...
Avadel Pharmaceuticals plc(AVDL) - 2021 Q2 - Quarterly Report
2021-08-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28508 ——————— AVADEL PHARMACEUTICALS PLC (Exact name of registrant as specified in its charter) ——————— (State or Other Ju ...
Avadel Pharmaceuticals plc(AVDL) - 2021 Q1 - Earnings Call Transcript
2021-05-10 17:22
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2021 Earnings Conference Call May 10, 2021 8:30 AM ET Company Participants Tom McHugh - Chief Financial Officer Greg Divis - Chief Executive Officer Jennifer Gudeman - Vice President of Medical and Clinical Affairs Richard Kim - Chief Commercial Officer Conference Call Participants Paul Matteis - Stifel David Amsellem - Piper Sandler Francois Brisebois - Oppenheimer Madhu Yennawar - SVB Leerink David Sherman - Lifesci Capital Robin Garner - Craig-Hallum Oren Livna ...
Avadel Pharmaceuticals plc(AVDL) - 2020 Q4 - Earnings Call Transcript
2021-03-09 19:11
Start Time: 08:30 January 1, 0000 9:25 AM ET Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2020 Earnings Conference Call March 09, 2021, 08:30 AM ET Company Participants Greg Divis - CEO Thomas McHugh - CFO Richard Kim - Chief Commercial Officer Jennifer Gudeman - VP of Medical and Clinical Affairs Conference Call Participants Eason Lee - SVB Leerink Thor Nagel - Stifel David Amsellem - Piper Jaffray Francois Brisebois - Oppenheimer David Sherman - Lifesci Capital Matthew Kaplan - Ladenburg Thalmann Robin Gar ...
Avadel Pharmaceuticals plc(AVDL) - 2020 Q4 - Annual Report
2021-03-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period ____________ to ____________ Commission file number: 000-28508 AVADEL PHARMACEUTICALS PLC (Exact name of registrant as specified in its charter) Ireland 98-1341933 State or other ...